Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid Review
Drug, Healthcare and Patient Safety · 2021-11 · Volume 13 · 233-240
DOI: 10.2147/dhps.s304373 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug, Healthcare and Patient Safety, 2021-11. Verfasst von Flavia Lo Castro und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Toxicology, Headache and Drug Abuse Research Center, Department of Specialized Medicine, AOU Policlinico di Modena, Modena, Italy. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Toxicology, Headache and Drug Abuse Research Center, Department of Specialized Medicine, AOU Policlinico di Modena, Modena, Italy.
- Danish Headache Center, Department of Neurology, Rigshospitalet Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Flavia Lo Castro, Lanfranco Pellesi
Zitieren
APA
Lo Castro, F., Guerzoni, S., & Pellesi, L. (2021). Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid Review. Drug, Healthcare and Patient Safety, Volume 13, 233-240. https://doi.org/10.2147/dhps.s304373
Vancouver
Lo Castro F, Guerzoni S, Pellesi L. Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid Review. Drug, Healthcare and Patient Safety. 2021;Volume 13:233-240. doi:10.2147/dhps.s304373
BibTeX
@article{LoCastro2021,
author = {Lo Castro, Flavia and Guerzoni, Simona and Pellesi, Lanfranco},
title = {Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid Review},
journal = {Drug, Healthcare and Patient Safety},
year = {2021},
volume = {Volume 13},
pages = {233--240},
doi = {10.2147/dhps.s304373}
}
EUVIMED